Behavioral Health Business features our CMO on expanding TMS access
We’re grateful to Behavioral Health Business for featuring insights from our Chief Medical Officer, John Fleming, MD, DLFAPA, FCTMSS, on expanding access to TMS.
What changed
The article covers a forward-thinking policy change from Optum that allows psychiatric nurse practitioners to provide TMS treatment in states that grant them full practice authority. It’s a meaningful step toward aligning payer rules with how care is actually delivered.
Dr. Fleming emphasized that when states grant full autonomy to practitioners, it’s encouraging to see payers follow suit.
Why it matters
This reflects exactly what we see in the field: artificial barriers that keep patients from accessing proven interventional treatments. As the article notes, TMS is increasingly becoming a front-line, first-option treatment rather than a last resort — and policy changes like this one help make that shift real.
When states grant full autonomy to practitioners, it’s great to see payers follow suit.
— John Fleming, MD, Chief Medical Officer, Everbright Health
Our part in it
At Everbright Health, we’re working to eliminate these access barriers by embedding full-service, end-to-end managed interventional psychiatry programs — including TMS, SPRAVATO®, and other FDA-approved treatments — directly into behavioral health practices. That way providers can focus on patient care instead of operational complexity.
Ready to bring advanced care to your patients?
Tell us about your practice and we'll put together a customized ROI analysis.